Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations T. D. Bjornsson Review Pages: 1 - 14
Influence of partial hepatectomy in rats on the activity of hepatic microsomal enzymatic systems A. M. MazaA. R. GasconJ. L. Pedraz OriginalPaper Pages: 15 - 23
Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849) in rats M. YabukiJ. ShimakuraI. Nakatsuka OriginalPaper Pages: 25 - 33
Ciprofloxacin decreases plasma phenytoin concentrations in the rat M. S. Al-Humayyd OriginalPaper Pages: 35 - 39
An approach for determination of chronopharmacokinetic parameters of methotrexate K. Mansour OriginalPaper Pages: 41 - 45
Pharmacokinetics of a new oral formulation of amoxicillin M-H. PrevotF. JehlB. Rouveix OriginalPaper Pages: 47 - 52
Disposition of DX-52-1, a novel anticancer agent, after intravenous administration to mice and dogs E. FuseH. NishiieS. Kobayashi OriginalPaper Pages: 53 - 63
Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs K. G. ToftS. O. HustvedtT. Skotland OriginalPaper Pages: 65 - 72
Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract ofSerenoa repens (Permixon®) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-β-sitosterol G. ChevalierP. BenardT. Bengone OriginalPaper Pages: 73 - 83
